Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Dare Bioscience, Inc. (DARE)

Daré Bioscience furnishes corporate presentation dated October 1, 2026 in 8-K

Neutral Impact 1 of 5 other Written later

Daré Bioscience filed a Form 8-K furnishing a corporate presentation dated October 1, 2026, to be used in meetings with securities market participants beginning that day. The filing is a routine disclosure under Regulation FD and contains no reported financial results, guidance, or transactions.

Key points

  • Corporate presentation dated October 1, 2026 furnished as Exhibit 99.1
  • Company will use the presentation in meetings with securities market participants starting October 1, 2026
  • A copy will be posted in the Investors section of the company's website; the information is furnished, not filed

The filing

CompanyDare Bioscience, Inc. (DARE)
Form8-K, current report
Filed with the SECOct 1, 2026, 9:00 AM ET
Accession number0001493152-26-045275

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 01, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.